Active substance
Tetracaine
- SFDA 3
- US FDA 3
- Health Canada 3
- US price lines 1
- NHS prices 3
- WHO EML 1
- Safety 5
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| MINIMS TETRACAINE HCL 1% | 1 % | Eye drops, solution · Ophthalmic use | 20 Single Dose Container | SAR 60.05 | NCE · Prescription | CHAUVIN BAUSCH & LOMB | Valid |
| MINIMS TETRACAINE HCL 0.5% | 0.5 % | Eye drops, solution · Ocular use | 20 Single Dose Container | SAR 25.10 | NCE · Prescription | CHAUVIN BAUSCH & LOMB | Withdrawn by MAH · Not Marketed |
| TETRACAINE DROPS | 0.5 % | Eye drops · Ocular use | 1 Dropper Container | SAR 17.70 | NCE · Prescription | ALCON COUVREUR | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
ANESTHESIA
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| TETRACAINE HYDROCHLORIDE | 0.5% | solution · ophthalmic | ALCON LABS | Prescription | 29 Feb 2016 |
| TETRACAINE HYDROCHLORIDE | 0.5% | solution · ophthalmic | BAUSCH LOMB IRELAND | Prescription | 12 Mar 2019 |
| TETRACAINE HYDROCHLORIDE | 0.5% | solution · ophthalmic | SOMERSET THERAPS LLC | Prescription | 20 Dec 2024 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| AMETOP GEL 4% | 02230575 | 40 MG / G | GEL · TOPICAL | VALEO PHARMA INC |
| MINIMS TETRACAINE HYDROCHLORIDE | 02148528 | 0.5 % / W/V | DROPS · OPHTHALMIC | BAUSCH & LOMB INC |
| MINIMS TETRACAINE HYDROCHLORIDE | 02148544 | 1 % / W/V | DROPS · OPHTHALMIC | BAUSCH & LOMB INC |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | TETRACAINE 0.5% EYE DROP | $4.32983 | per ML | 23 Sep 2026 |
| NHS Drug Tariff | Tetracaine 0.5% eye drops 0.5ml unit dose preservative free | £12.43 | 20 unit dose | 1 Oct 2026 |
| NHS Drug Tariff | Tetracaine 1% eye drops 0.5ml unit dose preservative free | £12.43 | 20 unit dose | 1 Oct 2026 |
| NHS Drug Tariff | Tetracaine 4% gel | £1.20 | 1.5 gram | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
WHO WHO Model List of Essential Medicines (2025)
- 21.3. Ophthalmological preparations > Local anaesthetics · core
Local anaesthetics
Local > Ophthalmological > Solution (eye drops): 0.5% (hydrochloride)
Safety signals and safety-related labeling changes
- US FDA 28 Feb 2022 TETRACAINE HYDROCHLORIDE — safety-related labeling change
Labeling sections changed: Warnings and Precautions - US FDA 22 Feb 2022 TETRACAINE HYDROCHLORIDE — safety-related labeling change
Labeling sections changed: Warnings and Precautions - US FDA 16 Dec 2020 SYNERA — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Drug Interactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide - US FDA 11 Dec 2018 PLIAGLIS — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Adverse Reactions; Drug Interactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide - US FDA 2 Nov 2018 KOVANAZE — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Drug Interactions; Patient Counseling Information / Patient Information / Medication Guide
Combinations containing Tetracaine
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.